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Abstract
Background: Accidental poisoning by methadone occurs, particularly as a result of children
ingesting a parent's methadone. Health care professionals have a responsibility to provide
information and guidance to methadone users on safe storage of methadone. The objective of the
study was to audit the effectiveness of information giving on the safety of methadone consumption,
dose measurement and storage, and the effectiveness of sources of advice available for patients.
Methods: The study was undertaken prior to the introduction of a scheme for the supervised
consumption of methadone, in the setting of an NHS Methadone clinic serving a district population
of 490,000 in the UK. 185 consecutive patients attending a methadone clinic to collect a methadone
prescription were the subject of an anonymous survey. Issues of safety of methadone consumption,
storage and safety information provisions were assessed. A telephone survey of the community
pharmacists dispensing the methadone covered the availability of measuring devices and provision
of advice on safety was undertaken.
Results: Methadone was stored in a variety of locations, a cupboard being most frequent. 95
patients (60.1%) had children either living in or visiting their home. All stored their methadone in
a bottle with a child resistant lid; the majority measured doses using either the container supplied
by the pharmacist or a plastic measure. 126 patients (78%) confirmed that a pharmacist provided a
measuring container on their first visit, 24 (15%) were given a measure on every visit to the
pharmacist. Advice on safe storage was recalled by 30% of the patients, and advice on measuring
methadone by 28%. Methadone was seen as potentially dangerous by 82% of the patients.
Conclusion: The risks resulting from unsafe storage of methadone may be reduced by daily
instalment prescribing and provision of measuring containers on request. Recall of provision of
information on safety issues is poor and the adoption of a standard policy on provision information
should be seen as a priority. A re-audit of safety of storage of methadone is recommended
following the introduction of a standard policy on information provision.
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Background
The number of prescriptions per year for methadone in
England increased from 425,400 to 1,318,100 between
1990 and 2001 [1]. Prior to the introduction in 1999 of
national guidelines in England [2] with regard to super-
vised methadone consumption, it was common practice
for patients to be prescribed take-home methadone from
specialist drug clinics or general practitioners which
would be dispensed at community pharmacies. Up to 14
days' supply could be prescribed on one prescription and
the patient would be allowed to store this at home. In
practice, prior to the development of supervised metha-
done schemes, where patients consume their methadone
at the pharmacy and are observed by the pharmacist,
many prescribers controlled the amount dispensed by
prescribing daily instalments or for 2 to 3 days at a time to
reduce the risk of diversion of supplies and the risk of stor-
age of high volumes. Following the introduction of guide-
lines for supervised methadone, it became the norm
within the UK for patients to have daily methadone pre-
scriptions with supervised consumption at the pharmacy
for a minimum of 3 months. Providing that they are com-
pliant with treatment, this supervision can then be discon-
tinued and increasing numbers of days' supply can be
dispensed to take home. Even within the current super-
vised schemes, patients will take home at least one day's
supply for unsupervised consumption as pharmacies are
not in general open on Sundays.
The introduction of national guidelines has produced
some changes in the prescribing methods for methadone
in the UK. There is still considerable variation in practice
between clinicians both in the dose prescribed and the
volume dispensed for take-home use [3]
The risks relating to methadone are not confined to those
prescribed methadone or to adults using illicit supplies.
The storage of methadone at home poses a potential risk
to children living with the person prescribed methadone
if the supply is not safely stored.
The value of oral methadone prescribing in the treatment
of opiate addicts is confirmed in National Clinical Guide-
lines [2]. Safety issues relating to storage of methadone at
home have been well documented [4]. A report regarding
the use of babies' feeding bottles as measuring devices for
methadone highlighted the risks to children of access to
methadone. The study recommended that all doctors who
prescribe methadone should ask their patients how they
measure their daily dose of methadone[5]. It is clear from
current guidance that health care professionals have a
responsibility to provide information and guidance to
methadone users on safe storage of methadone. [6]. We
undertook this audit to evaluate the effectiveness of the
sources of advice that those prescribed methadone may
have used with regard to safety of storage and measure-
ment of their methadone dose.
Methods
Audit criteria and standard setting
The audit followed a standard audit methodology of
selecting appropriate criteria and then selecting standards
by which to measure success in achieving the criteria.
Criteria
The following criteria were selected following a review of
the literature.
1. All patients prescribed methadone should recall being
given information on safe storage of methadone
2. All patients who take home methadone should have it
dispensed in a child resistant container
3. All patients prescribed methadone for home consump-
tion should have an accurate measuring device available
4. All patients who have methadone at home should store
it a child resistant container within a safe locked location.
5. All patients where children may have access to metha-
done should be aware of the particular risks to children.
6. All patients prescribed methadone should be aware of
the risks of accidental overdose.
Standards
The standard setting was agreed by the audit team using
the following principles.
1. Given the high risks posed by accidental methadone
overdose criteria 1 – 6 were allocated a 100% standard
Development of survey instruments
We devised and piloted a questionnaire for anonymous
self completion by patients. The content of the question-
naire was planned to cover the following aspects.
• Volumes of methadone prescribed and stored
• Frequency of pick up of prescriptions
• Frequency of doses
• Location of storage
• Measurement of methadone
• Possible access to the stored methadone by childrenHarm Reduction Journal 2005, 2:9 http://www.harmreductionjournal.com/content/2/1/9
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• Sources of advice on safe storage and measurement
• Appreciation of the possible risks of methadone.
A checklist for telephone survey of community pharma-
cists was devised to collect data on the availability of
measuring devices and advice on safety aspects of storage
and measurement.
Subjects
Patient survey
Over a period of three days, consecutive patients attend-
ing to collect a methadone prescription from the specialist
clinic were invited to complete the questionnaire. Of the
185 patients attending, 165 (86.4%) completed the
questionnaire.
Pharmacist survey
All pharmacists recorded in the clinic register as poten-
tially dispensing methadone to patients attending the
clinic were contacted by telephone (n = 48). Of these, 36
were actually dispensing methadone during the period of
the patient survey and 35 (97.2%) agreed to complete the
telephone survey
Results
Data analysis
Closed questions were analysed with descriptive statistics,
open questions by content analysis, a χ2 test was used to
compare outcomes
Volume of methadone stored at home
The mean daily methadone dose for the 161 patients was
32 mg, (Range 5 mg to 80 mg, SD = 14.01). Instalment
prescribing is the norm within the clinic and 97 patients
(63%) reported a daily pick up, 52 (34%) a pick up every
2 days, 3 patients (2%) picked up twice a week whilst 1
patient (<1%) reported a weekly pick up.
Volumes stored at home reflected the range of doses and
the type of instalment prescribing. The mean volume
stored at home was 51 mg (Range 0 mg to 315 mg, SD=
48.3). Of the 11 patients who reported that they did not
store any methadone at home, 2 reported that they stored
it about their person, 8 consumed all their methadone in
the street after it had been dispensed and 1 gave it to a par-
ent for safekeeping.
Location of storage
Content analysis of the location of storage revealed a vari-
ety of locations (Table 1). A cupboard was the most com-
mon storage place 49 (30.6%), 27 (16.8%) stored
methadone in the fridge, whilst only 4 patients (2.5%)
stored methadone in a medicine cabinet. One patient
stored methadone in a wastebin
Safety of storage
Of the 159 patients who completed the item on security
of their place of storage, 43 (27%) acknowledged that
other people would have access to their storage place.
The presence of children in the house was assessed in two
ways, firstly as an item enquiring as to children resident
with the patient and secondly an item regarding children
who may visit the patient. From these items a consoli-
dated figure of homes where children may have access to
methadone was calculated.
158 patients responded to items on children within the
home, of whom 95 (60.1%) had children either living in
or visiting the home. An assessment by these 95 patients
of the risk of children knowing where the methadone was
stored resulted in 5 patients (3.2%) accepting that chil-
dren would know where they kept their methadone, 10
patients (6.45%) reported that they thought children
could find their methadone.
Chi square analysis of methadone storage location and
assessment of the ability of others to access the storage site
showed no significant difference between the group with
children living in or visiting their home and those with no
children living in or having access to their home.
Methadone storage container
Of the 160 patients who completed the questionnaire,
100% stored their methadone in the original pharmacists'
container supplied with a child resistant cap.
Measurement of methadone
An open question with regard to containers used to meas-
ure out methadone doses revealed a fairly narrow range of
containers to be in use (Table 2). 140 patients (67.5%)
used either the container supplied by the pharmacist or a
plastic measure supplied by the pharmacist to measure
Table 1: Location of storage of methadone in the home
No response 12 (7.50%)
Wardrobe 7 (4.38%)
Kitchen 7 (4.38%)
On person 4 (2.50%)
Medicine cabinet 4 (2.50%)
Shelf 4 (2.50%)
Mum's House 2 (1.25%)
Unspecified 2 (1.25%)
Bathroom 2 (1.25%)
Living room 1 (0.63%)
Bag 1 (0.63%)
Wastebin 1 (0.63%)
Drawer 1 (0.63%)Harm Reduction Journal 2005, 2:9 http://www.harmreductionjournal.com/content/2/1/9
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out their methadone; a minority of 5 patients (3.13%)
guessed the correct amount without any form of measure.
The need to measure out methadone occurs when more
than one days supply is dispensed, such as at weekends or
when patients have a less frequent prescription instal-
ment. The need to measure out methadone also occurs
when patients split their daily dose. Responses to the sur-
vey indicated that of the 153 who responded to this item,
100 (63%) take their methadone as single dose. The
remaining patients split their dose, 52 (34%) taking
methadone twice a day, and 4 (3%) taking it three or more
times a day.
126 patients (78%) confirmed provision of measuring
containers on the first visit to a pharmacist. 24 patients
(15%) reported that they were given a measuring con-
tainer on every visit to the pharmacist and 13 (8%)
reported that they were able to request a measuring device
when they needed one
Sources of advice on storage and measurement
Only 49 patients (31%) recalled being given advice on
safety of methadone; of those who did recall this advice,
it had been given by the Methadone Clinic (41.7%), the
local drug agency (27%) or the pharmacist (21%).
Advice on ways to measure out methadone was recalled
by 45 patients (28%), this advice had been given by the
methadone clinic (40%), the pharmacist (36%) or the
local drug agency (18%).
Knowledge of the risks of methadone
In response to the question " Is methadone dangerous?".
131 patients (82%) replied yes, 25 patients (16%) replied
no and 3 (2%) did not respond. None of the patients
reported having being involved with any accidental use of
methadone.
Pharmacist survey
Of the 35 pharmacists who participated in the survey, 32
(91%) confirmed that they would provide a measuring
device on request. Only 5 (14.3%) provided a measuring
device on each attendance.
Advice on storage of methadone had been given by 4
pharmacists (11%) and advice on measuring out metha-
done by 6 (17%).
The pharmacists were each dispensing for a mean of 5
patients (Range 1 to 20, SD 4.4)
Audit criteria
Performance on criteria 1 to 6 was measured against the
defined standards. The results are summarised in table 3.
Only 1 of the standards reached 100% in the sample stud-
ied, that being the dispensing of methadone in containers
with child resistant caps.
Discussion
The accidental ingestion of methadone is a well recog-
nised risk of methadone prescribing[7,8] The need to
store methadone is increased if prescriptions are dis-
pensed in more than daily instalments. A survey of pre-
scribing to opiate addicts in England and Wales in 1996
showed that up to 36% of prescriptions for methadone
were dispensed on a weekly basis [9]. The use of inappro-
priate storage and measuring containers for methadone,
such as babies' bottles by over 25% of patients in Dublin,
was perhaps influenced by the fact that over 50 % of pre-
scriptions for methadone in Dublin were dispensed on a
weekly basis [5].
The routine supply of measuring containers is not neces-
sary when methadone is dispensed on a daily basis or its
consumption is supervised, apart from at weekends and
when the patient takes the methadone in divided doses.
The pharmacists surveyed in this study were able to pro-
vide measuring containers on request and the patients
appeared to be aware of this facility and had obtained
them when needed.
The provision of advice to patients on safe storage and
measurement had been received by a minority of patients.
Pharmacists confirmed that they had only given advice to
a small proportion of the patients.
The level of advice reported appears to be consistent with
that reported by Calman et al [4] in 1996, as do the vari-
ous locations chosen by patients to store methadone. The
patients' responses to the present study do however indi-
cate a high level of awareness of the risks of methadone
both to children and to non drug using adults.
The risks associated with methadone storage and meas-
urement can be seen to be reduced by daily instalment
Table 2: Measuring Methadone (n = 160)
Measuring device Number (%)
Plastic Measure 100 (62.50%)
Pharmacist's dispensing container 40 (25.00%)
Bottle Cap 10 (6.25%)
Guessing Amount 5 (3.13%)
Injection Syringe 3 (1.88%)
Spoon 1 (0.63%)
Cup 1 (0.63%)Harm Reduction Journal 2005, 2:9 http://www.harmreductionjournal.com/content/2/1/9
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prescribing, provision of measuring devices on request
and the provision of information on the particular risks of
methadone to children.
The risks to children of unsafe storage of medicines is not
of course confined to methadone. Studies of accidental
poisoning of children from prescribed medications have
shown consistently that failure to store medication in a
child resistant container in a safe location is a major factor
in increasing the risk of accidental poisoning [10,11]
The responsibility for giving advice on these matters does
not appear to be allocated to any one agency and our
study reveals that many patients do not recall being given
such advice. Provision of information on safety issues is
poor and the adoption of a standard policy on provision
of written information should be seen as a priority.
A survey of community pharmacists in Scotland under-
taken by Matheson and Bond [12] indicated that pharma-
cists providing health promotion advice to drug misusers
see verbal advice as being "risky", whereas written infor-
mation is seen as non-confrontational. The introduction
of written information on storage and measurement to be
given out at the time of dispensing of methadone may be
one possible solution to ensuring that patients remain
aware of the risks inherent in irresponsible custody of
their methadone and what steps to take to reduce this risk.
Studies of the relative effectiveness of written versus verbal
information on patient information retention and subse-
quent action do not, however, show any advantage of
written over verbal presentation[13,14]. The overall view
is that providing the information in both forms provides
a range of options which may match the patients' pre-
ferred mode of receiving information.
Conclusion
The provision of information on the safe storage of meth-
adone is recalled by a minority of patients, and the vast
majority of patients do not store their methadone in a
locked cupboard or other secure location.
The audit we have reported will be repeated following the
provision of written information to patients in addition to
verbal information at the point that they commence their
methadone treatment. This will be reinforced at the point
where patients transfer from supervised consumption at
the pharmacy to home consumption as part of a progres-
sive relaxation of restrictions in more stable patients.
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